Turning White Fat Brown: Scientists Unveil Promising New Obesity Treatment
- BY Anna Origins
- November 13, 2024
- 0 Comments
The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo Therapeutics LLC, a late-stage preclinical biopharmaceutical company focused on developing treatments for obesity and related metabolic disorders, recently presented findings f
Seasonal Affective Disorder: What is SAD? Symptoms, treatment and how to beat the winter blues
- BY Anna Origins
- November 11, 2024
- 0 Comments
The cold days and dark nights during the autumn and winter months are enough to make anyone feel glum, and as the bad weather draws in once more, it makes sense that this would affect our mood too. But if you’re consistently finding yourself in low spirits and it’s beginning to affect your everyday life, […]
Approaches to holistic obesity treatment and identifying healthful behaviors
- BY Anna Origins
- November 11, 2024
- 0 Comments
October 31, 2024 3 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try again […]
SELECT ‘legitimized obesity medical therapy’ for treatment of cardiometabolic disease
- BY Anna Origins
- November 11, 2024
- 0 Comments
November 04, 2024 6 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try again […]
Incretin-based therapies for the treatment of obesity-related diseases
- BY Anna Origins
- November 11, 2024
- 0 Comments
Chong, B. et al. Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019. EClinicalMedicine 57, 101850 (2023). Article PubMed PubMed Central Google Scholar Tan, Q. et al. Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes. Front. Endocrinol. 13, […]
Mind and body wellness during cancer treatment
- BY Anna Origins
- November 11, 2024
- 0 Comments
CityLine: Mind and body wellness during cancer treatment Ellie Fund offers a range of supports to promote health for patients. Updated: 12:30 PM EDT Oct 27, 2024 MORE THAN 360,000 PEOPLE WILL BE DIAGNOSED WITH BREAST CANCER THIS YEAR IN THE U.S., BLACK WOMEN ARE 40% MORE LIKELY TO DIE FROM BREAST CANCER COMPARED TO […]
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
- BY Anna Origins
- November 11, 2024
- 0 Comments
1 Introduction In the past decade, obesity and related co-morbidities have become critical public health problems and serious medical conditions worldwide (1). A state of positive energy balance exists in the duration of the energy intake exceeding energy consumption, resulting in the storage of the excess calories in adipose tissue, which first leads to body […]
Adipo Therapeutics presents positive study results about potential obesity treatment
- BY Anna Origins
- November 11, 2024
- 0 Comments
Findings provide encouraging evidence to advance ADPO-002NP treatment toward first-in-human Phase I clinical trials Meng Deng, an associate professor in Purdue University’s colleges of Agriculture and Engineering, is founder of Adipo Therapeutics LLC. The biopharmaceutical company presented data about its active ingredient and lead product at the annual meeting of The Obesity Society. (The ESC […]
Are GLP-1s the Newest Fertility Treatment?
- BY Anna Origins
- November 11, 2024
- 0 Comments
First, there were “Ozempic babies.” Now, there is also Ozempic-before-baby. Unplanned pregnancies are still regularly being reported among people using glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, and now fertility specialists are increasingly incorporating the medicines into preconception care plans. The specialists say their colleagues in other areas of medicine may have an opportunity, […]